Aims-To determine which inflammatory and immune pathways are implicated in the development of chronic graft versus host disease (GvHD) and whether differences between these pathways are responsible for the different presentations of chronic GvHD. 
Chronic graft versus host disease (GvHD) is one of the most disabling complications of bone marrow transplantation (BMT). About 30-50% of transplant recipients still living three months after transplantation will present with features of this disease.' 2In contrast to acute GvHD, where a cytotoxic reaction driven by donor T lymphocytes against host antigens has been demonstrated,3 4the pathogenesis of chronic GvHD is poorly understood. Evidence for an interaction between anti-host and autoimmune phenomena is described frequently,5-'0 but the precise pathways leading to the development of the lesions are still unclear. Lymphocytes, cytokines and adhesion molecules in chronic graft versus host disease CONTROLS VCAM-1 expression was not observed in any of the allogeneic BMT recipients with other skin conditions. IL1a and E-selectin were expressed in two of five of these patients. A lymphocytic infiltrate was not observed in patients who underwent total body irradiation followed by autologous BMT. ILla and E-selectin were expressed in two of four patients who had received radiotherapy for less than one year.
APOPTOSIS
Numerous keratinocytic nuclei were labelled in both GvHD types ( fig 8A) . Labelled keratinocytes were present mainly in the basal layer and in the suprabasal to a lesser degree, especially in patients with lichen planus-like GvHD. Follicular keratinocytes were also labelled (data not shown). Staining was not observed in controls and in normal skin from patients with GvHD ( fig 8B) .
Discussion
Chronic GvHD is a multisystemic disease which mainly involves the skin, mouth and liver. Its pathogenesis seems to be the consequence of a complex interaction between antihost and auto-immune phenomena. Perforin, part of the major cytotoxicity pathway,22 does not seem to play a role in chronic ILla, TNFa and CD54 were expressed in diseased epidermis and E-selectin in dermal vessels. These molecules can be chemotactic for T cells and permit strong adhesion of lymphocytes to endothelium or keratinocytes and therefore may contribute to the development of cutaneous GvHD. TNFa, E-selectin and VCAM-1 are expressed in skin specimens of patients with systemic sclerosis, an autoimmune disease which is clinically very similar to sclerodermatous GvHD.28 29 The lack of VCAM-1 expression in the specimens of sclerodermatous GvHD in the present study suggests that different pathogenetic mechanisms are involved in these two diseases. Our results show that VCAM- 1 4 A better understanding of the role of E-selectin and ILI x in the pathogenesis of chronic GvHD may be forthcoming on analysis of these molecules at day 100 after BMT.
In conclusion, chronic cutaneous GvHD seems to occur secondary to the infiltration by T cells which in turn induce apoptosis of keratinocytes, possibly via the production of Fas ligand. T 
